Autism has been shown to have a major genetic risk component; the architecture of documented autism in families has been over and again shown to be passed down for generations. While inherited risk plays an important role in the autistic nature of children, de novo (germline) mutations have also been implicated in autism risk. Here we find that autism de novo variants verified and published in the literature are Bonferronisignificantly enriched in a gene set implicated in synaptic elimination. Additionally, several of the genes in this synaptic elimination set that were enriched in protein-protein interactions (CACNA1C, SHANK2, SYNGAP1, NLGN3, NRXN1, and PTEN) have been previously confirmed as genes that confer risk for the disorder. The results demonstrate that autism-associated de novos are linked to proper synaptic pruning and density, hinting at the etiology of autism and suggesting pathophysiology for downstream correction and treatment.
Introduction
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder that impairs social skills, communication, and normal behavior. About 1% of the world's population has ASD, and this number is rapidly rising: the prevalence of autism more than doubled between 2002 and 2012 1 . ASD-linked impairment leads to higher lifespan costs 2 and a significant reduction in ability to procure both postgraduate education and jobs 3 . Both inherited (present in mother or father) and de novo (germline) mutations have been shown to contribute to the disease 4 . Although several of each type appear to contribute to ASD risk, there is still not a clear picture or full map of what leads to ASD 5 . Several hypotheses exist for the genetic etiology of autism; one of note is referred to as the "synaptic elimination hypothesis," the exploration of which is the focus of this paper.
Synaptic elimination is a normal neurodevelopmental process, starting in the fifth week of development and continuing throughout life. The process occurs in parallel with synaptic formation, which relies on input from both presynaptic and postsynaptic neurons. Elimination eventually outpaces formation in adolescence and adulthood 6, 7 . During the development of the central nervous system, neurons form multiple synapses in excess of functional need. These redundant synapses are later eliminated through various means: 1) loss of signals necessary from either presynaptic or postsynaptic neurons to maintain synaptic stability 8 ; 2) apoptosis of synapses; 3) ubiquitination of synaptic proteins for proteosomal degradation 9 ; 4) macroautophagy 7 ; or 5) phagocytosis of synapses as a result of opsonization by synaptic eliminationmediating complement factors, microglia, and astrocytes [10] [11] [12] [13] . Previous work has shown that faulty synaptic formation and maturation contribute to ASD 6 . However, given that increases in both dendritic spine density and brain weight (both of which are characteristic of autism) can be caused by mutations in genes regulating synaptic elimination, the hypothesis developed that autism could also be a disease of abnormal synaptic elimination 8, [14] [15] [16] . Currently, the major pathway and ontology databases (KEGG, GO, Panther, and Reactome) do not contain any gene sets that pertain to synaptic elimination or synaptic pruning. As part of this study, we endeavored to create a robust and manually curated list of genes contributing to synaptic elimination; our goal was to test the hypothesis that the curated gene set would be enriched for de novo mutations (see Supplemental Materials 2 and 3 for list of genes and references used to generate this list, respectively). We hypothesized that increased burden of mutations in synaptic elimination genes would lead to the synaptic pruning abnormalities observed in autism, such as increased dendritic spine density and increased brain weight.
We used the dnenrich package 17 , a network burden analysis tool, to test for enrichment in the synaptic elimination gene set on a comprehensive set of exomes from family-based trios having one child with autism. The package has been shown to be particularly powerful for identifying de novo mutations with small individual association to phenotype, but large effect in combination. We used dnenrich on previously documented autism-associated gene sets and autism-associated de novos as a pilot. This was done to verify that the program was suitable for use with autism de novos and that our list of de novos was large enough to provide sufficient power to detect enrichment of certain gene sets. After doing so, we tested the hypothesis that our list of genes involved in synaptic elimination would have a higher burden of autism de novos than would be expected by chance. 
Methods

Autism de novo variants
We downloaded genomes of 3982 autism family trios from the Autism Sequencing Consortium (ASC) and the Simons Simplex Collection (SSC) [18] [19] [20] . These cohorts have been studied from a single-variant perspective, but have not yet been examined for their potential relationship to the synaptic elimination network.
Focusing on previously published full exome data, we built a comprehensive database of genomic variants to test for enrichment of synaptic elimination [18] [19] [20] [21] 18 . The full variant list from this collection, which also includes ASC cohorts, were compared to a larger set of 1,779 other exomes to confirm their putative roles in autism, and all de novo events were validated via PCR amplification and Sanger sequencing 22 . Family quads selected from SSC were sequenced with enrichment for higher functioning probands 19, 20 . These de novos were interpreted using pipeline tools at each respective participating data center.
Dnenrich Pilot Study
Dnenrich simulates peppering the genome with random de novos by taking into account trinucleotide contexts, gene sizes, sequencing coverage, and functional effects of mutations. After permuting this process for a user-defined number of times, it then calculates one-sided P values, testing whether the observed number of mutations (in each gene set) is greater than the average simulated number of mutations (again, in each gene set).
We assembled 37 candidate gene sets to test their enrichment in our curated list of autism de novo variation. These 37 gene sets included Gene Ontology sets from previous autism network analyses 24, 25 , as well as genes shown to interact with FMRP (a mutation in which causes Fragile X syndrome, one of the most common causes of autism spectrum disorders) 21, 26 . A full list of genes in each set tested for enrichment can be found in Supplemental Materials 1, along with their sizes.
We then performed an extensive process of literature mining and curation, through combined database search, hand-search, and related reference review, to assemble the synaptic elimination gene set. Our Pubmed search (conducted between May and June., 2016) included use of the terms "synapse," "synaptic," "elimination," "pruning," and "gene." We then performed additional handsearches of Nature and Cell using the same terms. References of included studies, review articles, and related references were screened for additional relevant studies based on title and abstract review. Our screening criteria for inclusion in the synaptic elimination set was the presence of the following terms: "synaptic elimination," "synaptic pruning," "synaptic stabilization," "synaptic destabilization," and "synaptic plasticity." In all searches we excluded the following terms: "axon scaling," "viral infection," "axon repulsion," "axon retraction," and "neuromuscular junction." Studies pertaining to synaptic formation, maintenance, and/or elimination within the peripheral nervous system were excluded on the basis of arising from separate embryologic origin than the central nervous system. Abstracts and unpublished data were excluded. The synaptic elimination gene set was curated through careful review of 120 selected studies and related reviews yielding 274 genes related to synaptic formation or elimination. Gene function was crossreferenced in ClinVar (accessed July 11, 2016), and 213 genes of interest were selected based on their role in synaptic elimination (see Supplemental Materials 2). After its curation, we tested the synaptic elimination gene set for enrichment for autism de novos. CD22  LEPR  CD55  MEF2  SPARC   GAS6  DR6  CD47  IGFBP3  TLR2  MEF2A  DYRK1A   EN2  GDA  TSPAN7  PAK3  CTNNB1  WNT2  FOXP1   MEF2B  REL  NLGN1  SEMA3A  BDNF  CHN2  RCAN1   MEF2C  RELA  NLGN2  SEMA3F  DHCR7  MAPK3  CHD8   MEF2D  RELB  NLGN3  NRP1  FMR1  MAPK1  RAC1   PARK2  SERPINA3 NLGN4  NRP2  AUTS10  TSC1  OPHN1   caspases CUL3  SHANK1  RhoA  LAMC3  TSC2  FOXP2   hdc  ESCRT-I  SHANK2  ROCK1  MECP2  DOCK1  ARC   MIB1  shrub  SHANK3  OTX1  THBS1  EPHA4  CASK   UBE3A  ESCRT-III CNTN4  DISC1  THBS2  EPHB3  DLG4   UBE3B  CHMP2B  CNTNAP2 KATNAL2 THBS4  EFNA4  HOMER1 PCDH10 mop
Results
We tested the 37 initial gene sets with dnenrich with the default gene size matrix provided on the dnenrich website (as adjusting for per-trio joint sequencing coverage "[does] not have a noticeable effect on results" 17 ). We ran the simulation on the downloaded autism de novos for 5000 permutations without weighting any genes. Of the 37 gene sets tested, 10 were significantly enriched for de novos after Bonferroni adjustment for 37 hypotheses. These sets are listed in Table   Pacific Symposium on Biocomputing 2017 2. Given the enrichment of de novos in known autism networks calculated by dnenrich, we felt confident in using both this set of previously-published de novos and dnenrich to test the single hypothesis that synaptic elimination genes would have an exceedingly high burden of de novos. Consistent with the synaptic elimination hypothesis, the synaptic elimination set also proved to be significantly enriched for autism de novo mutations (p = 1.9996*10 -4 ). It exceeded the observed-to-expected mutation ratio of all other significantly enriched gene sets (Figure 2) . Ratio of observed-to-expected mutations per enriched gene set. The dnenrich software calculated expected number of mutations by simulating and averaging the number of de novo events in each gene set using information like tri-nucleotide context, gene size, etc. The systematically-generated synaptic elimination set has the highest ratio of observed-to-expected mutations by a significant margin.
To narrow the list of 213 genes in the synaptic elimination set down to a shorter list of genes to prioritize, we used DAPPLE. Developed by Elizabeth Rossin of the Broad Institute, the algorithm marks genes that are ripe for further study 28 . DAPPLE relies on protein-protein interaction databases such as InWeb (populated with hundreds of thousands of known protein-protein interactions). When researchers input a network, the algorithm compares the network it to what would be expected by pure probability by permuting proteins (linked to the inputted genes) many times. It determines if genes in all of the inputted regions could play a role in disease, and tests whether or not the network is more connected than would be expected by chance. For our purposes, this analysis would point to genes of interest within our synaptic elimination network that have higher levels of interconnectivity than expected.
Using DAPPLE (Figure 3 ) on the synaptic elimination gene set yielded fifty-four genes significantly enriched for protein-protein interactions (PPI), which are listed in Table 3 . Six of these fifty-four (CACNA1C, SHANK2, SYNGAP1, NLGN3, NRXN1, and PTEN) have already been confirmed as genes associated with autism risk 27 . Those genes that were enriched were visualized using the STRING database ( Figure 4 ) in order to examine other known (and predicted) gene interactions. Further inquiry into these resultant genes involved in synaptic elimination could elucidate etiology and shed light on related ASD risk. DAPPLE visualization of the synaptic elimination gene set. DAPPLE analyzes the protein-protein interaction network generated by the genes in the set; it marks the genes that are significantly more connected in the network than by chance (PPI-enriched). The nodes represent genes in the network, and the edges represent interactions between proteins downstream of the connected genes. The graphic is arbitrarily colored and is meant to show connectivity only. 
Discussion
Overall, our results supported the hypothesis that genes involved in synaptic elimination are significantly enriched for autism de novo mutations, pointing to deregulation in synaptic elimination as a potential pathogenic mechanism for ASD. Synaptic elimination, as part of the larger synaptic homeostatic mechanism, contributes to higher structural and functional connectivity underlying cognitive functions through the removal of synaptic structures. Several of the genes that were PPI-enriched in the gene set were confirmed autism disease genes, suggesting that the genes central to the synaptic elimination network may play an important role in influencing genetic risk for autism. Given the biological plausibility of this pathway, along with the enrichment for de novos in known autism cases, the additional genes in this pathway may serve as candidate genes in the future investigation of the genetic etiology of autism spectrum disorder.
Within the context of the hypothesis that de novo mutations contribute to the risk of developing ASD in families with no previous history, previous gene enrichment studies have focused on identification of these de novo mutations and their interconnections as a multifaceted network without exploration of specific neurodevelopmental processes 22 . In the present study, we took advantage of a large collection of full exomes from trios with one affected child. This enabled us to explore the role of de novo mutations in synaptic density and pruning, confirming that there is a strong link and supporting the potential value of these de novos for use in increasing precision in early diagnosis/prognosis.
The lack of a validation cohort is a drawback of this study. A new set of de novos is currently undergoing quality control procedures; we will attempt to replicate this signal in a much larger collection of families. A consortium that includes our group has amassed over 5000 whole genomes (30x coverage) in multiplex families containing 2 or more children with autism. This is the largest database of its kind and valuable for determining whether the de novo signal seen replicates across siblings and families with varying levels of autism severity. In addition, it may be worthwhile to consider the genes involved in synaptic formation or maintenance in addition to those involved in elimination. Gene sets like the GO Neuron Development or Cell-cell Signaling sets, which showed significant de novo mutation enrichment, provide a good starting point for future studies, as neuronal activity and signaling play a definitive role in determining synapse strength and number.
More work is necessary to determine the biological implications of the association between synaptic elimination and autism. For the PPI-enriched genes in the synaptic elimination network, many of which have validated associations with autism, the exact process by which they affect brain development leading to behavioral change is unclear. The true role of these genes in the pathophysiology of autism must be elucidated by future science.
Network analyses like these have successfully been able to identify and validate gene sets that contribute risk to ASD and other neuropsychiatric disorders. The high likelihood that these findings are reproducible in the context of newer, more complete, and more specific datasets bolsters the hope of eventually having a more complete picture of ASD risk factors that impact precision care of this complex disorder. Such a map would be invaluable to both the diagnosis and subsequent treatment of ASD; synaptic elimination may play a key role in that map. 
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